Skip to content
OpenCapital
Get started

Danaher DHR Biotechnology — Segment Reporting, Other Segment Item, Amount

Other segment segments

Diagnostics
$1.86B+15.9%
Life Sciences
$1.44B+3.4%

Similar metrics at other companies

CryoPort, Inc. logo
CYRXLife Sciences Products — Segment Reporting Other Item Amount
$1.48M+34.2%
CryoPort, Inc. logo
CYRXLife Sciences Services — Segment Reporting Other Item Amount
$4.04M+17.4%
PTC Therapeutics logo
PTCTLife Science — Segment Reporting Other Item Amount
$107.89M-25.8%
OFG Bancorp logo
OFGBanking — Segment Reporting, Other Segment Item, Amount
$15.09M+3.3%
Huntington Ingalls Industries logo
HIIMission Technologies — Segment Reporting, Other Segment Item, Amount
$61M+13.0%
LyondellBasell Industries N.V. logo
LYBTechnology — Other items
$39M+14.7%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$134.62B-7.4%
Enterprise value$158.13B-1.7%
P/E33.6×-9.0×
P/S5.4×-0.7×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The official record: Danaher’s 10-Q, filed July 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Danaher's biotechnology — segment reporting, other segment item, amount.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Danaher's biotechnology — segment reporting, other segment item, amount?
Danaher (DHR) reported biotechnology — segment reporting, other segment item, amount of $1.09B in Q2 2026.
How has Danaher's biotechnology — segment reporting, other segment item, amount changed year-over-year?
Danaher's biotechnology — segment reporting, other segment item, amount increased by 3.8% year-over-year, from $1.05B to $1.09B.
What is the long-term trend for Danaher's biotechnology — segment reporting, other segment item, amount?
Over 3 years (2022 to 2025), Danaher's biotechnology — segment reporting, other segment item, amount has grown at a -3.3% compound annual growth rate (CAGR), from $4.75B to $4.29B.
What does biotechnology — segment reporting, other segment item, amount mean?
Captures miscellaneous operating items or adjustments specific to the biotechnology segment that do not fit into standard categories like depreciation or amortization. This may include restructuring costs, specific operational overheads, or segment-specific allocations. It provides visibility into the underlying operational costs not captured by primary expense lines.